Coronary endarterectomy (CE) represents a useful adjunctive technique to coronary artery bypass grafting (CABG) in the presence of diffuse coronary artery disease. Nevertheless, the long-term patency of the graft remains unclear, and no standard anticoagulation and antiplatelet protocols exist for use after CE. The aim of this retrospective study was to evaluate and possibly to clarify the role of single (SAT) versus dual antiplatelet therapy (DAT) at mid-term follow-up.
Russo, M., Nardi, P., Saitto, G., Bovio, E., Pellegrino, A., Scafuri, A., et al. (2017). Single versus double antiplatelet therapy in patients undergoing coronary artery bypass grafting with coronary endarterectomy: Mid-term results and clinical implications. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 24(2), 203-208 [10.1093/icvts/ivw351].
Single versus double antiplatelet therapy in patients undergoing coronary artery bypass grafting with coronary endarterectomy: Mid-term results and clinical implications
NARDI, PAOLO;PELLEGRINO, ANTONIO;SCAFURI, ANTONIO;RUVOLO, GIOVANNI
2017-01-01
Abstract
Coronary endarterectomy (CE) represents a useful adjunctive technique to coronary artery bypass grafting (CABG) in the presence of diffuse coronary artery disease. Nevertheless, the long-term patency of the graft remains unclear, and no standard anticoagulation and antiplatelet protocols exist for use after CE. The aim of this retrospective study was to evaluate and possibly to clarify the role of single (SAT) versus dual antiplatelet therapy (DAT) at mid-term follow-up.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
